U.S. Markets closed

GlaxoSmithKline Consumer Healthcare Limited (GSKCONS.NS)


NSE - NSE Real Time Price. Currency in INR
Add to watchlist
5,375.80-3.45 (-0.06%)
At close: 3:29PM IST
Full screen
Previous Close5,379.25
Open5,360.15
Bid5,375.80 x
Ask0.00 x
Day's Range5,350.00 - 5,398.95
52 Week Range4,708.00 - 6,600.00
Volume3,855
Avg. Volume10,529
Market Cap225.67B
BetaN/A
PE Ratio (TTM)34.43
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GSK's new CEO aims to divest sports nutrition brand: sources
    Reutersyesterday

    GSK's new CEO aims to divest sports nutrition brand: sources

    GlaxoSmithKline Plc's new Chief Executive Officer Emma Walmsley is shaking up the British drugmaker's portfolio of smaller products with plans to divest its MaxiNutrition sports nutrition brand, two people familiar with the matter said on Thursday. GSK bought the business, which makes protein bars, drinks and powders, for 162 million pounds ($205 million) in 2010 under previous CEO Andrew Witty. The original acquisition was seen as complementing GSK's Lucozade sports drinks.

  • Glaxo's (GSK) Shingles Candidate Phase III Data Positive
    Zacksyesterday

    Glaxo's (GSK) Shingles Candidate Phase III Data Positive

    GlaxoSmithKline plc (GSK) announced positive top-line results from a phase III revaccination study on its shingles vaccine candidate, Shingrix, in older patients.

  • CNBCyesterday

    Early movers: ORCL, HAIN, ACN, SCS, ATUS, NVS, GSK & more

    These are the stocks posting the largest moves before the bell.